Puma Biotechnology Inc (NASDAQ:PBYI)

3.19
Delayed Data
As of Aug 18
 0.00 / 0.00%
Today’s Change
1.60
Today|||52-Week Range
7.84
+4.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$159.9M

Company Description

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Contact Information

Puma Biotechnology, Inc.
10880 Wilshire Boulevard
Los Angeles California 90024-4101
P:(424) 248-6500
Investor Relations:
142424865002011

Employees

Shareholders

Other institutional45.89%
Individual stakeholders26.07%
Mutual fund holders16.96%

Top Executives

Alan H. AuerbachChairman, President, CEO & Secretary
Maximo F. NouguesChief Financial & Accounting Officer
Alvin WongChief Scientific Officer
Jeffrey LudwigChief Commercial Officer
Mariann OhanesianSenior Director-Investor Relations